News summarySeeking AlphaNov 6, 2026, 04:25 AM
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M(摘要待生成)
Loading...
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M(摘要待生成)